{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:02:21Z","timestamp":1784707341595,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10552-026-02210-8","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:20:52Z","timestamp":1783016452000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Construction and validation of a folate metabolism-related gene signature for prognosis prediction, immune landscape characterization, and molecular subtyping in glioma"],"prefix":"10.1007","volume":"37","author":[{"given":"Chen","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"issue":"1","key":"2210_CR1","first-page":"3","volume":"18","author":"F Hanif","year":"2017","unstructured":"Hanif F, Muzaffar K, Perveen K, Malhi SM, Simjee ShU (2017) Glioblastoma multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment. Asian Pac J Cancer Prev 18(1):3\u20139","journal-title":"Asian Pac J Cancer Prev"},{"key":"2210_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13020216","author":"L Bonosi","year":"2023","unstructured":"Bonosi L, Marrone S, Benigno UE, Buscemi F, Musso S, Porzio M et al (2023) Maximal safe resection in glioblastoma surgery: a systematic review of advanced intraoperative image-guided techniques. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci13020216","journal-title":"Brain Sci"},{"issue":"12","key":"2210_CR3","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/s41423-024-01226-x","volume":"21","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhou F, Ali H, Lathia JD, Chen P (2024) Immunotherapy for glioblastoma: current state, challenges, and future perspectives. Cell Mol Immunol 21(12):1354\u20131375","journal-title":"Cell Mol Immunol"},{"key":"2210_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cells13181574","author":"AI Cortes Ballen","year":"2024","unstructured":"Cortes Ballen AI, Amosu M, Ravinder S, Chan J, Derin E, Slika H et al (2024) Metabolic reprogramming in glioblastoma multiforme: a review of pathways and therapeutic targets. Cells. https:\/\/doi.org\/10.3390\/cells13181574","journal-title":"Cells"},{"key":"2210_CR5","doi-asserted-by":"publisher","first-page":"1292944","DOI":"10.3389\/fendo.2023.1292944","volume":"14","author":"X Yan","year":"2023","unstructured":"Yan X, Li J, Zhang Y, Liang C, Liang P, Li T et al (2023) Alterations in cellular metabolism under different grades of glioma staging identified based on a multi-omics analysis strategy. Front Endocrinol 14:1292944","journal-title":"Front Endocrinol"},{"issue":"3","key":"2210_CR6","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.drudis.2020.12.006","volume":"26","author":"C Yang","year":"2021","unstructured":"Yang C, Zhang J, Liao M, Yang Y, Wang Y, Yuan Y et al (2021) Folate-mediated one-carbon metabolism: a targeting strategy in cancer therapy. Drug Discov Today 26(3):817\u2013825","journal-title":"Drug Discov Today"},{"issue":"3","key":"2210_CR7","doi-asserted-by":"publisher","first-page":"444","DOI":"10.21037\/tcr-21-2485","volume":"11","author":"J Du","year":"2022","unstructured":"Du J, Huang Y, Jing S, Pei Y, Qian Y, Zeng Y (2022) Serine hydroxymethyltransferase 2 predicts unfavorable outcomes in multiple cancer: a systematic review and meta-analysis. Transl Cancer Res 11(3):444\u2013455","journal-title":"Transl Cancer Res"},{"key":"2210_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13123067","author":"K Ghannad-Zadeh","year":"2021","unstructured":"Ghannad-Zadeh K, Das S (2021) One-carbon metabolism associated vulnerabilities in glioblastoma: a review. Cancers. https:\/\/doi.org\/10.3390\/cancers13123067","journal-title":"Cancers"},{"issue":"1","key":"2210_CR9","doi-asserted-by":"publisher","first-page":"eaat0456","DOI":"10.1126\/sciadv.aat0456","volume":"5","author":"JL May","year":"2019","unstructured":"May JL, Kouri FM, Hurley LA, Liu J, Tommasini-Ghelfi S, Ji Y et al (2019) IDH3\u03b1 regulates one-carbon metabolism in glioblastoma. Sci Adv 5(1):eaat0456","journal-title":"Sci Adv"},{"issue":"6","key":"2210_CR10","doi-asserted-by":"publisher","first-page":"lnad048","DOI":"10.1093\/lifemedi\/lnad048","volume":"2","author":"XC He","year":"2023","unstructured":"He XC, Wang J, Shi MY, Liu CM, Teng ZQ (2023) Hypoxia-induced one-carbon metabolic reprogramming in glioma stem-like cells. Life Med 2(6):lnad048","journal-title":"Life Med"},{"issue":"7547","key":"2210_CR11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nature14363","volume":"520","author":"D Kim","year":"2015","unstructured":"Kim D, Fiske BP, Birsoy K, Freinkman E, Kami K, Possemato RL et al (2015) SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance. Nature 520(7547):363\u2013367","journal-title":"Nature"},{"issue":"12","key":"2210_CR12","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1158\/2159-8290.CD-14-1228","volume":"4","author":"I Mart\u00ednez-Reyes","year":"2014","unstructured":"Mart\u00ednez-Reyes I, Chandel NS (2014) Mitochondrial one-carbon metabolism maintains redox balance during hypoxia. Cancer Discov 4(12):1371\u20131373","journal-title":"Cancer Discov"},{"issue":"1","key":"2210_CR13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/s12967-023-04185-5","volume":"21","author":"Y Sun","year":"2023","unstructured":"Sun Y, Mu G, Xue Z, Li X, Lin X, Han M (2023) Pharmacological targeting of one\u2011carbon metabolism as a novel therapeutic strategy for glioblastoma. J Transl Med 21(1):424","journal-title":"J Transl Med"},{"issue":"1","key":"2210_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3945\/an.111.000992","volume":"3","author":"KS Crider","year":"2012","unstructured":"Crider KS, Yang TP, Berry RJ, Bailey LB (2012) Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate\u2019s role. Adv Nutr 3(1):21\u201338","journal-title":"Adv Nutr"},{"issue":"4","key":"2210_CR15","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10142-023-01205-x","volume":"23","author":"X Liu","year":"2023","unstructured":"Liu X, Chen C, Xu P, Chen B, Xu A, Liu C (2023) Development and experimental validation of a folate metabolism-related gene signature to predict the prognosis and immunotherapeutic sensitivity in bladder cancer. Funct Integr Genomics 23(4):291","journal-title":"Funct Integr Genomics"},{"issue":"4","key":"2210_CR16","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1002\/iid3.515","volume":"9","author":"Q Yuan","year":"2021","unstructured":"Yuan Q, Wang SQ, Zhang GT, He J, Liu ZD, Wang MR et al (2021) Highly expressed of SERPINA3 indicated poor prognosis and involved in immune suppression in glioma. Immun Inflamm Dis 9(4):1618\u20131630","journal-title":"Immun Inflamm Dis"},{"issue":"4","key":"2210_CR17","doi-asserted-by":"publisher","first-page":"210350","DOI":"10.1098\/rsob.210350","volume":"12","author":"B Phasaludeen","year":"2022","unstructured":"Phasaludeen B, Emerald BS, Ansari SA (2022) The epigenetic-metabolic interplay in gliomagenesis. Open Biol 12(4):210350","journal-title":"Open Biol"},{"key":"2210_CR18","doi-asserted-by":"publisher","first-page":"657472","DOI":"10.3389\/fcell.2021.657472","volume":"9","author":"H Zhu","year":"2021","unstructured":"Zhu H, Yu X, Zhang S, Shu K (2021) Targeting the complement pathway in malignant glioma microenvironments. Front Cell Dev Biol 9:657472","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2210_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/neup.12535","volume":"39","author":"K Masui","year":"2019","unstructured":"Masui K, Onizuka H, Cavenee WK, Mischel PS, Shibata N (2019) Metabolic reprogramming in the pathogenesis of glioma: update. Neuropathology 39(1):3\u201313","journal-title":"Neuropathology"},{"key":"2210_CR20","doi-asserted-by":"publisher","first-page":"101566","DOI":"10.1016\/j.tranon.2022.101566","volume":"27","author":"H Kuhn","year":"2023","unstructured":"Kuhn H, Frille A, Petersen MA, Oberhuber-Kurth J, Hofmann L, Gl\u00e4ser A et al (2023) IGFBP3 inhibits tumor growth and invasion of lung cancer cells and is associated with improved survival in lung cancer patients. Transl Oncol 27:101566","journal-title":"Transl Oncol"},{"issue":"1","key":"2210_CR21","doi-asserted-by":"publisher","first-page":"2088467","DOI":"10.1080\/2162402X.2022.2088467","volume":"11","author":"D Lin","year":"2022","unstructured":"Lin D, Mei Y, Lei L, Binte Hanafi Z, Jin Z, Liu Y et al (2022) Immune suppressive function of IL-1\u03b1 release in the tumor microenvironment regulated by calpain 1. Oncoimmunology 11(1):2088467","journal-title":"Oncoimmunology"},{"issue":"2","key":"2210_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/nan.12428","volume":"44","author":"MD S\u00f8rensen","year":"2018","unstructured":"S\u00f8rensen MD, Dahlrot RH, Boldt HB, Hansen S, Kristensen BW (2018) Tumour-associated microglia\/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumour subtype. Neuropathol Appl Neurobiol 44(2):185\u2013206","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2210_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13174255","author":"RS Andersen","year":"2021","unstructured":"Andersen RS, Anand A, Harwood DSL, Kristensen BW (2021) Tumor-associated microglia and macrophages in the glioblastoma microenvironment and their implications for therapy. Cancers. https:\/\/doi.org\/10.3390\/cancers13174255","journal-title":"Cancers"},{"key":"2210_CR24","doi-asserted-by":"publisher","first-page":"1123853","DOI":"10.3389\/fimmu.2023.1123853","volume":"14","author":"C Lin","year":"2023","unstructured":"Lin C, Wang N, Xu C (2023) Glioma-associated microglia\/macrophages (GAMs) in glioblastoma: immune function in the tumor microenvironment and implications for immunotherapy. Front Immunol 14:1123853","journal-title":"Front Immunol"},{"issue":"12","key":"2210_CR25","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1002\/1878-0261.13657","volume":"18","author":"G Solomou","year":"2024","unstructured":"Solomou G, Young AMH, Bulstrode H (2024) Microglia and macrophages in glioblastoma: landscapes and treatment directions. Mol Oncol 18(12):2906\u20132926","journal-title":"Mol Oncol"},{"issue":"7","key":"2210_CR26","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.cmet.2023.06.003","volume":"35","author":"W Zou","year":"2023","unstructured":"Zou W, Green DR (2023) Beggars banquet: metabolism in the tumor immune microenvironment and cancer therapy. Cell Metab 35(7):1101\u20131113","journal-title":"Cell Metab"},{"issue":"5","key":"2210_CR27","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/j.apsb.2023.12.004","volume":"14","author":"L Wang","year":"2024","unstructured":"Wang L, Zhang J, Zhang W, Zheng M, Guo H, Pan X et al (2024) The inhibitory effect of adenosine on tumor adaptive immunity and intervention strategies. Acta Pharm Sin B 14(5):1951\u20131964","journal-title":"Acta Pharm Sin B"},{"issue":"4","key":"2210_CR28","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s00432-024-05731-4","volume":"150","author":"L Wang","year":"2024","unstructured":"Wang L, He Y, Bai Y, Zhang S, Pang B, Chen A et al (2024) Construction and validation of a folate metabolism-related gene signature for predicting prognosis in HNSCC. J Cancer Res Clin Oncol 150(4):198","journal-title":"J Cancer Res Clin Oncol"},{"key":"2210_CR29","doi-asserted-by":"publisher","first-page":"1021678","DOI":"10.3389\/fimmu.2023.1021678","volume":"14","author":"J Li","year":"2023","unstructured":"Li J, Zhang S, Chen S, Yuan Y, Zuo M, Li T et al (2023) Lipid metabolism-related gene signature predicts prognosis and depicts tumor microenvironment immune landscape in gliomas. Front Immunol 14:1021678","journal-title":"Front Immunol"},{"key":"2210_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179339","author":"AF Sobral","year":"2024","unstructured":"Sobral AF, Cunha A, Silva V, Gil-Martins E, Silva R, Barbosa DJ (2024) Unveiling the therapeutic potential of folate-dependent one-carbon metabolism in cancer and neurodegeneration. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25179339","journal-title":"Int J Mol Sci"},{"key":"2210_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008339","author":"J Shen","year":"2024","unstructured":"Shen J, Choi YL, Lee T, Kim H, Chae YK, Dulken BW et al (2024) Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2023-008339","journal-title":"J Immunother Cancer"},{"issue":"6","key":"2210_CR32","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1038\/s41375-021-01189-2","volume":"35","author":"MM Zarou","year":"2021","unstructured":"Zarou MM, Vazquez A, Vignir Helgason G (2021) Folate metabolism: a re-emerging therapeutic target in haematological cancers. Leukemia 35(6):1539\u20131551","journal-title":"Leukemia"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-026-02210-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-026-02210-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-026-02210-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T07:23:49Z","timestamp":1784705029000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-026-02210-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2210"],"URL":"https:\/\/doi.org\/10.1007\/s10552-026-02210-8","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"3 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"120"}}